摘要
目的:探讨艾迪注射液对晚期原发性肝癌的临床治疗效果。方法:选取2010年1月—2015年4月在我院住院治疗的晚期原发性肝癌患者共36例,将其随机分为治疗组和对照组2组,分别接受常规药物治疗(对照组,n=18)及常规药物治疗加上应用中药艾迪注射液(治疗组,n=18)治疗。结果:与对照组相比,使用了艾迪注射液治疗的患者其生活质量及生存期得到提高,且毒性反应和副作用较小。结论:艾迪注射液对晚期原发性肝癌有较好的疗效,可在临床广泛推广应用。
Objective： To explore the clinical curative effect of Aidi injection on advanced liver cancer. Methods： 36 Patients with advanced liver cancer in our hospital from January 2010 to April 2015 were divided into control group and treatment group by the random number table. The control group （18cases） was treated with conventional drug therapy and the treatment group （18cases） was added Aidi injection based on the control group. Results： Compared with the control group, the quality of life and the survival of patients with Aidi injection were improved effectively and the toxicity was small. Conclusion： Aidi injection has a good effect on patients with advanced liver cancer and it can be promoted to the clinic.
出处
《中医临床研究》
2015年第21期119-120,共2页
Clinical Journal Of Chinese Medicine
基金
河南省医学科技攻关计划项目(201303211)
关键词
艾迪注射液
原发性肝癌
晚期
中药
Aidi Injection
Primary Liver Cancer
Advanced
Chinese Medicine
